STOCKSCREENR
Log In

BRKR

NASDAQ

Bruker Corporation

$33.74+0.98(+2.99%)Mkt Cap: $5.14B

Key Stats

Market Cap

$5.14B

P/E Ratio

-224.93

EPS

$-0.15

Dividend Yield

0.54%

52-Week Range

$28.53 — $56.22

Volume

1.83M

Avg Volume

2.40M

Beta

1.19

Valuation

P/E (TTM)

-224.93

Forward P/E

15.92

PEG Ratio

-105.20

P/S (TTM)

1.65

P/B (TTM)

2.30

P/FCF

-91.16

EV/EBITDA

2156.90x

EV/Sales

—

Financial Health

ROE (TTM)

-0.00%

ROA (TTM)

-0.00%

ROIC

0.01%

Gross Margin

0.47%

Operating Margin

0.05%

Net Margin

-0.07%

Debt/Equity

0.83

Current Ratio

1.73

Growth

EPS Growth (YoY)

-2.45%

Revenue Growth (YoY)

-0.01%

EPS Growth (3Y)

-0.49%

EPS Growth (5Y)

-0.12%

Sales Growth (3Y)

+0.11%

Sales Growth (5Y)

+0.12%

EPS Est (This Year)

$2.12

EPS Est (Next Year)

$2.42

Dividends

Dividend Yield

—

Annual Dividend

$0.05

Payout Ratio

-0.13%

Frequency

—

Ex-Dividend Date

2025-12-08

Cash/Share

$1.97

Analyst Consensus

2.0

Buy

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$35.00$52.50$60.00
LowMedianHigh

Consensus Target: $52.13(54.5% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

152.22M

Float

103.58M

Free Float %

68.05%

Technicals

RSI (14)

22.54

SMA 20

$46.45

SMA 50

$47.49

SMA 200

$40.40

ATR (14)

1.88

Volatility (Week)

0.02%

Volatility (Month)

0.03%

Pattern

—

Performance

1 Day

-1.24%

1 Week

-2.53%

1 Month

-23.65%

3 Months

+4.13%

6 Months

+35.09%

1 Year

—

YTD

-13.57%

All-Time High

$57.64

About

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

NASDAQ

IPO Date

2000-08-04

Employees

11396

CEO

Frank H. Laukien

Index Membership

—

Website

https://www.bruker.com

Bruker Corporation (BRKR) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $5.14B, a P/E ratio of -224.93, and a dividend yield of 0.54%, BRKR is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BRKR against other stocks using dozens of fundamental and technical filters.

Similar Stocks

SNN

Smith & Nephew plc

$33.37

+0.85%

$14.34B

PEN

Penumbra, Inc.

$338.00

+0.53%

$13.26B

BIO

Bio-Rad Laboratories, Inc.

$269.48

+3.15%

$7.27B

AHCO

AdaptHealth Corp.

$10.45

+0.29%

$1.42B

IRMD

IRadimed Corporation

$102.80

+1.09%

$1.31B

CNMD

CONMED Corporation

$37.34

-0.19%

$1.16B

Frequently Asked Questions

What is Bruker Corporation's P/E ratio?

Bruker Corporation (BRKR) has a trailing twelve-month (TTM) P/E ratio of -224.93. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Bruker Corporation pay a dividend?

No, Bruker Corporation (BRKR) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Bruker Corporation's market cap?

Bruker Corporation (BRKR) has a market capitalization of $5.14 billion, classifying it as a mid-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about BRKR?

Wall Street analysts have a consensus "Buy" rating on Bruker Corporation (BRKR) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $52.13 implies 54.5% upside from the current price.

How has BRKR performed this year?

Bruker Corporation (BRKR) has returned -13.57% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.